My Site 2 Group

Once upon a time there was a lovely princess. But she had an enchantment upon her of a fearful sort, which could only be broken by Love's first kiss. She was locked away in a castle guarded by a terrible fire breathing dragon. Many brave knights had attempted to free her from this dreadful prison, but none prevailed. She waited in the dragon's keep in the highest room of the tallest tower for her true love and true love's first kiss. Like that's ever going to happen. What a loony. Shrek Beware Stay out I think he's in here. All right. Lets get it! Hold on. Do you know what that thing can do to you? Yeah. He'll groan into your bones for his brains. Well actually that would be a giant. Now Ogres, huh, they are much worse. They'll make a soup from your freshly peeled skin. They'll chew…

Not sure how I came across this, but my son is dreaming of high level performance. This seems like there has not been a legitimate post on this site ever.

The Influx of Capital: Analyzing the Role of Government Funding and Venture Capital in Accelerating Nanobots Research and Commercialization in Asia

The extraordinary growth trajectory of the Asia Pacific nanobots market is fundamentally underpinned by a significant and increasing influx of capital from both government bodies and private investors. Governments across the region, recognizing the strategic importance of nanotechnology as an enabling technology for national competitiveness and public health, are allocating substantial funds to research and development. This financial support is crucial, as nanorobotics research is inherently capital-intensive, requiring advanced equipment and long-term commitment. This public funding, particularly prominent in nations like China, Japan, and South Korea, provides the foundation for academic institutions to make fundamental scientific breakthroughs. Simultaneously, venture capital firms and private sector entities, particularly biopharmaceutical companies, are accelerating their investments, drawn by the immense commercial potential of applications like targeted drug delivery and advanced diagnostics. The biopharmaceutical…